Harold Bernstein, President, R&D & CMO at Maze Therapeutics, Inc. (MAZE), sold 29,900 shares at $44.20 ($1.4M) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Open-market sale of $1.4M MAZE by President, R&D & CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.20 | 600 | $27K | 1.9% |
| 2 | $44.21 | 600 | $27K | 1.9% |
| 3 | $45.89 | 8,364 | $384K | 27.9% |
| 4 | $45.89 | 8,364 | $384K | 27.9% |
| 5 | $46.37 | 5,936 | $275K | 20.0% |
| 6 | $46.37 | 5,936 |
| $275K |
| 20.0% |
| 7 | $47.23 | 100 | $5K | 0.3% |
| Total | $46.02 avg | 29,900 | $1.4M | 100% |
| Filing → |
| MAZE | SELL | 2026-09-04 | $270K | — | Filing → |
| MAZE | SELL | 2026-09-03 | $426K | — | Filing → |
| MAZE | SELL | 2026-08-14 | $446K | — | Filing → |